Vice President of Molecular Diagnostics R&D Fapon Biotech Inc. Boston, Massachusetts, United States
Enzymes are pivotal in molecular diagnostics, acting as crucial enablers that open up broad opportunities for downstream applications. This presentation demonstrates how advancements in enzyme engineering have significantly improved PCR, NGS, and isothermal amplification, greatly advancing fields such as oncology, infectious disease detection, and clinical screening. Continuous innovation in enzyme technology fosters the development of diverse and sophisticated molecular solutions, driving new possibilities and expanding the potential of downstream clinical applications.
